Nova (FRA:NMR) Marketable Securities: €777.9 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:NMR Nova Ltd FRA:NMR
97 GF Score
Price €345.10
GF Value €295.22
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Nova Marketable Securities?

Nova FRA:NMR -4.98% 97 Marketable Securities is €777.9 Mil as of Jun. 2026. GuruFocus rates FRA:NMR with a GF Score™ of 97/100 and a GF Value™ of €295.22 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Nova's Marketable Securities for the quarter that ended in Jun. 2026 was €777.9 Mil.

Nova's annual Marketable Securities increased from Dec. 2023 (€308.2 Mil) to Dec. 2024 (€409.5 Mil) and increased from Dec. 2024 (€409.5 Mil) to Dec. 2025 (€712.3 Mil).

Nova  (FRA:NMR) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Nova Marketable Securities Related Terms

Nova Marketable Securities Historical Data

* Premium members only.

The historical data trend for Nova's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nova Marketable Securities Chart

Nova Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 250.87 247.69 308.21 409.49 712.28

Nova Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 343.52 482.56 712.28 585.37 777.86
FRA:NMR
97GF Score
Nova Ltd FRA:NMR
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nova Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of €777.9 Mil mean?
Nova (FRA:NMR) has a Marketable Securities of €777.9 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Nova and its competitors.
Is Nova's Marketable Securities too high?
Nova's current Marketable Securities is €777.9 Mil. Overall, Nova has a GF Score™ of 97/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nova's Marketable Securities compare to ONTO and AMKR?
Nova's Marketable Securities of €777.9 Mil can be compared against companies in the Semiconductors industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Semiconductors company?
A good Marketable Securities depends on the Semiconductors industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Nova and its competitors. Nova's current Marketable Securities is €777.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nova stock overvalued right now?
Based on GuruFocus' analysis, Nova (FRA:NMR) is currently considered Modestly Overvalued. The stock's GF Value™ is €295.22, compared to a current price of €345.10 — trading 16.9% above its estimated fair value. The current Marketable Securities is €777.9 Mil. Nova's overall GF Score™ is 97/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Nova (FRA:NMR), the current Marketable Securities is €777.9 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nova (FRA:NMR) Overvalued in 2026?

Based on GuruFocus' analysis, Nova stock appears to be overvalued. The current stock price of €345.10 is trading 16.9% above its estimated GF Value™ of €295.22. GuruFocus considers Nova to be Modestly Overvalued.

Key valuation signals for FRA:NMR:

  • Marketable Securities: €777.9 Mil
  • GF Value™: €295.22 vs. price of €345.10 (16.9% above fair value)
  • GF Score™: 97/100 with 4 warning signs

No single metric tells the full story. See the FRA:NMR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nova Business Description

Other Exchanges NVMI:USANVMI:Israel0YAA:UK
Address 5 David Fikes Street, 10th Floor, Rehovot, ISR, 7632805
Nova Ltd is a provider of metrology and process control solutions used in semiconductor manufacturing. The company provides high-performance metrology solutions across the semiconductor fabrication lifecycle and develops differentiated inline metrology solutions deployed by a broad range of customers, including integrated circuit manufacturers. Its portfolio combines high-precision hardware and software, enabling customers to improve device performance, enhance yields, and accelerate time to market. Its products include Dimensional Metrology, Materials Metrology, Chemical Metrology, and Software Solutions. The company operates in China, Taiwan, R.O.C., the United States and other regions, with maximum revenue coming from China.
97GF Score

Get the complete analysis for FRA:NMR

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€345.10
Price
€295.22
GF Value